glp 1 and alzheimers GLP-1 improves the neuronal supportive ability of astrocytes in Alzheimer's disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway GLP-1 Receptor Agonists in Neurodegeneration:
Description
AST, aspartate transaminase
PMID 15090972
Studies are demonstrating a plethora of positive effects on cardiovascular health, renal disease and liver disease, which may be directly related to the mitigation of the diabetes or obesity-associated risks of these complications or possibly direct protective effects
GLP-1s main responsibilities are to stimulate insulin secretion and to inhibit glucagon secretion, contributing to limit the rise and fall of glucose levels after meals
For weight loss, semaglutide is a prescription medication that requires a healthcare providers guidance
